Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Gori A, Doroana M, Chernova O, Rockstroh JK, Banhegyi D, Bergin C, Verucchi G, Liu C, DeMasi R, Hadacek B, Nelson M. Telaprevir-based therapy for treatment of HIV-1 and hepatitis C virus co-infected patients: An early access programme. J Infect 2015;71:675-82. [PMID: 26416471 DOI: 10.1016/j.jinf.2015.09.013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2015] [Accepted: 09/20/2015] [Indexed: 11/16/2022]

For:	Gori A, Doroana M, Chernova O, Rockstroh JK, Banhegyi D, Bergin C, Verucchi G, Liu C, DeMasi R, Hadacek B, Nelson M. Telaprevir-based therapy for treatment of HIV-1 and hepatitis C virus co-infected patients: An early access programme. J Infect 2015;71:675-82. [PMID: 26416471 DOI: 10.1016/j.jinf.2015.09.013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2015] [Accepted: 09/20/2015] [Indexed: 11/16/2022]

Number	Cited by Other Article(s)
1	Carvalho L, Pillai S, Daniels E, Sellers P, Whyte R, Eveson L, Foxton M, Nelson M. Higher sustained virological response rates at 12 weeks in HIV-HCV co-infection; a tertiary centre experience. J Infect 2020;80:232-254. [DOI: 10.1016/j.jinf.2019.10.019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Accepted: 10/26/2019] [Indexed: 11/28/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse Collaborators Collapse

Number

Cited by Other Article(s)

Carvalho L, Pillai S, Daniels E, Sellers P, Whyte R, Eveson L, Foxton M, Nelson M. Higher sustained virological response rates at 12 weeks in HIV-HCV co-infection; a tertiary centre experience. J Infect 2020;80:232-254. [DOI: 10.1016/j.jinf.2019.10.019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Accepted: 10/26/2019] [Indexed: 11/28/2022]